The Fate Of The MD In The $12 Million Patient Safety Scandal

Dr. Charles Denham, a physician-turned-entrepreneur-and-activist, has agreed to pay $1 million to settle government charges of taking a $12 million kickback to influence a national patient safety standard in favor of one company’s product. Though the l…

Read more

The Fate Of The MD In The $12 Million Patient Safety Scandal

Dr. Charles Denham, a physician-turned-entrepreneur-and-activist, has agreed to pay $1 million to settle government charges of taking a $12 million kickback to influence a national patient safety standard in favor of one company’s product. Though the l…

Read more

Race, Ethnicity and Patient Engagement

By MICHAEL MILLENSON A few years ago, I was upgraded to First Class on a flight from California back to Chicago. Not long after I settled in, a tall, muscular man easily four inches taller than me walked up to my aisle seat in the first row and prepared to sit by the window. I envisioned […]

Read more

How Mayo’s “Dr. Google” Deal Disrupts Medicine

The deal to produce clinical summaries under the Mayo Clinic name for Google searches symbolizes the medical priesthood’s acceptance that information technology has reshaped the doctor-patient relationship. More disruptions are already on the way.

Read more

How Mayo’s “Dr. Google” Deal Disrupts Medicine

The deal to produce clinical summaries under the Mayo Clinic name for Google searches symbolizes the medical priesthood’s acceptance that information technology has reshaped the doctor-patient relationship. More disruptions are already on the way.

Read more

A PR Pro’s “How To” on Earning Trust, Helping Earnings

After 15 years of asking consumers around the world about who they trust and why, Edelman CEO Richard Edelman offers advice on boosting trust and why it helps earnings and innovation.

Read more

A PR Pro’s “How To” on Earning Trust, Helping Earnings

After 15 years of asking consumers around the world about who they trust and why, Edelman CEO Richard Edelman offers advice on boosting trust and why it helps earnings and innovation.

Read more

Breast Cancer Tests Betray ‘Precision Medicine’ Branding

The biotech industry cheered President Obama’s proposed $215 million Precision Medicine Initiative, but the varying results and genetic basis of three DNA-based tests to predict breast cancer recurrence show the gap remaining between branding and real …

Read more

Breast Cancer Tests Betray ‘Precision Medicine’ Branding

The biotech industry cheered President Obama’s proposed $215 million Precision Medicine Initiative, but the varying results and genetic basis of three DNA-based tests to predict breast cancer recurrence show the gap remaining between branding and real …

Read more

Can Business Savvy, Clout And Charisma Supercharge Patient Safety?

Joe Kiani, the Iranian-born entrepreneur who built Masimo Corp., is behind a Patient Safety Movement that hopes to use the clout and charisma model of the Clinton Foundation to eliminate preventable medical errors by the year 2020.

Read more
Close
Go top